INSIGHTS

Insights that cut through complexity

Want the lowest-net-cost drugs? Change your thinking on disruption

Want the lowest-net-cost drugs? Change your thinking on disruption

It might seem like a lowest-net-cost formulary would be made up of clinically equivalent agents with the lowest overall cost.…
COVID-19 Treatment Developments

COVID-19 Treatment Developments

Introduction Recent data from Johns Hopkins University showed over 760,000 people in the U.S. have died from the coronavirus to…
Q3 2021 Drug Pipeline Recap

Q3 2021 Drug Pipeline Recap

The Latest Developments in Drug Approvals Each quarter, the RemedyOne Clinical team curates a drug pipeline report for our clients…
No One Really Knows How We’ll Pay for Gene Therapies

No One Really Knows How We’ll Pay for Gene Therapies

Gene therapies are here and they have the potential to be miraculous. And extremely expensive. The science behind these therapies…
COVID-19 Treatment Update

COVID-19 Treatment Update

The last year and a half brought many rapid changes and innovations across the globe and in no area more than healthcare. From finding the most effective treatments to developing tests and…
The Implications of Polypharmacy on the Payor and Patient

The Implications of Polypharmacy on the Payor and Patient

There is a delicate balance between prescribing new medications and identifying and eliminating unnecessary prescriptions to protect the overall care…
Like what you’re seeing? Get more Insights sent to you.
  • This field is for validation purposes and should be left unchanged.